Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Aging Cell|June 26, 2023
Bone dysplasia in Hutchinson-Gilford progeria syndrome is associated with dysregulated differentiation and function of bone cell populationsWayne A Cabral, Chris Stephan, Masahiko Terajima, et al.
Head & Neck|April 29, 2015
Translational treatment paradigm for managing non-unions secondary to radiation injury utilizing adipose derived stem cells and angiogenic therapyAlexis Donneys, Jordan T Blough, Noah S Nelson, et al.
Plos Genetics|June 27, 2014
Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfectaWayne A Cabral, Irina Perdivara, MaryAnn Weis, et al.
Journal of Periodontal Research|February 4, 2026
The Role of Wnt Signaling in Age-Related Alveolar Bone Loss and RegenerationHsiao H Sung, Navya Chalamalasetty, Ali Alzainal, et al.
Bone|January 15, 2013
Early detection of burn induced heterotopic ossification using transcutaneous Raman spectroscopyJonathan R Peterson, Paul I Okagbare, Sara De La Rosa, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 24, 2019
HR-pQCT Measures of Bone Microarchitecture Predict Fracture: Systematic Review and Meta-AnalysisNicholas Mikolajewicz, Nick Bishop, Andrew J Burghardt, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|March 1, 2020
Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasiaWayne A Cabral, Nadja Fratzl-Zelman, MaryAnn Weis, et al.
Bone Research|June 15, 2026
Murine model of high bone mass osteogenesis imperfecta exhibits bone matrix hyper-mineralization, misaligned mineral crystals, and altered osteoblast differentiationAileen M Barnes, M Helen Rajpar, Joseph E Perosky, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2018
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding studyS de Vos, L J Swinnen, D Wang, et al.
Pageof 14